eBook

eBook-Dosage Form Optimization for Patient-Centric Drug-Development Process

Developing new drugs is a risky endeavor for pharmaceutical companies. Patient-centric drug development and optimization is both a tool and a trend for drug development. By utilizing innovative formulation and drug delivery technologies in the early phases of development, pharmaceutical companies can designing products with the patient in mind and minimize the many risks they may encounter on the path to clinic and to market. Download this MUST-READ eBook to learn more about the strategies and technologies which can minimize the risks of developing new drugs and potentially improve their safety, efficacy, compliance, adherence, and availability to the widest possible patient populations.

Learn more about:

Optimizing Drug Design for Patient Outcomes: Challenges and Opportunities.

Early Phase Development Strategy for Better Drug Design.

A Clinical & Academic Perspective on Patient-Centric Drug Design.

Business Email Address*

First Name*

Last Name*

Company*

Title*

Business Phone

Country

State or Province

Buying Horizon*

Asset ID

Asset Type

Asset URL

Download Center - Date Stamp

Download Center - Visit Count

ZZ - Last SFDC Campaign ID

Unique ID

Browser

auxCountry

auxState

Why Catalent?

Catalyst + Talent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 70 billion doses of more than 7,000 products to over 1,000 customers annually. Catalent’s expert workforce exceeds 17,000, including more than 2,500 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year. For more information, visit www.catalent.com.

More products. Better treatments. Reliably supplied.™